Dr Reddy's Laboratories Ltd

Common Name
Dr Reddy's Laboratories
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
27,811
Ticker
DRREDDY
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Dr. Reddy's Laboratories Ltd. is a globally recognized pharmaceutical company specializing in the manufacturing and distribution of a wide array of therapeutic substances and active pharmaceutical ing...

Financial Statements of Dr Reddy's Laboratories

Below are the financial statements of Dr Reddy's Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in billions of INR20242023
Non-current assets
Property, plant and equipment
62.49a
56.54a
Capital work-in-progress
13.51a
9.75a
Goodwill
5.5a
5.47a
Other intangible assets
36.27a
30.18a
Intangible assets under development
0.68a
0.55a
Investment in equity accounted investees
4.2a
4.7a
Financial assets
Investments
1.06a
0.66a
Other financial assets
1.21a
0.73a
Deferred tax assets, net
10.58a
7.05a
Tax assets, net
3.72a
2.69a
Other non-current assets
1.37a
0.28a
Current assets
Inventories
63.55a
48.67a
Financial assets
Investments
44.05a
44.5a
Trade receivables
80.3a
72.49a
Derivative financial instruments
0.17a
1.23a
Cash and cash equivalents
7.11a
5.78a
Other bank balances
10.17a
11.52a
Other financial assets
22.53a
4.95a
Other current assets
20.18a
15.12a
Total assets
388.64a
322.85a
Equity
Equity share capital
0.83a
0.83a
Other equity
281.71a
232.03a
Financial liabilities
Borrowings
3.8a
0a
Lease liabilities
2.19a
1.28a
Non-current liabilities
Provisions
0.24a
0.2a
Deferred tax liabilities, net
0.84a
0.76a
Other non-current liabilities
3.14a
2.03a
Financial liabilities
Borrowings
12.72a
11.19a
Lease liabilities
1.31a
1a
Trade payables
Total outstanding dues of micro enterprises and small enterprises
0.28a
0.08a
Total outstanding dues of creditors other than micro enterprises and small enterprises
25.86a
22.6a
Derivative financial instruments
0.47a
0.14a
Other financial liabilities
34.54a
29.18a
Current liabilities
Liabilities for current tax, net
2.34a
2.14a
Provisions
6.92a
6.53a
Other current liabilities
11.44a
12.86a
Total equity and liabilities
388.64a
322.85a
Cash and cash equivalents
7.11a
5.78a
Other investments
74.36a
56.02a
Trade and other receivables
80.3a
72.49a
Inventories
63.55a
48.67a
Derivative financial instruments
0.17a
1.23a
Other current assets
22.56a
20.07a
Total current assets
248.05a
204.25a
Property, plant and equipment
76.89a
66.46a
Goodwill
4.25a
4.25a
Other intangible assets
36.95a
30.85a
Investment in equity accounted investees
4.2a
4.7a
Other investments
1.06a
0.66a
Deferred tax assets
10.77a
7.2a
Tax assets
3.72a
2.69a
Other non-current assets
1.63a
0.8a
Total non-current assets
139.47a
117.6a
Total assets
387.52a
321.85a
Current liabilities
Trade and other payables
30.92a
26.44a
Short-term borrowings
12.72a
7.39a
Long-term borrowings, current portion
1.31a
4.8a
Provisions
5.38a
5.45a
Tax liabilities
2.34a
2.14a
Derivative financial instruments
0.47a
0.14a
Other current liabilities
42.9a
39.47a
Total current liabilities
96.04a
85.85a
Non-current liabilities
Long-term borrowings
5.99a
1.28a
Deferred tax liabilities
0.91a
0.83a
Provisions
0.06a
0.06a
Other non-current liabilities
3.97a
2.85a
Total non-current liabilities
10.93a
5.02a

Verified Sources Behind Dr Reddy's Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dr Reddy's Laboratories’s data sources below and access millions more through our Disclosure Search.

a. Dr Reddy's Laboratories's Integrated Report 2024
Trace every data point back to Dr Reddy's Laboratories’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?